RAREbenzinga

Piper Sandler Maintains Overweight on Ultragenyx Pharmaceutical, Raises Price Target to $140

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on January 13, 2025 by benzinga